{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Liu S"],"pubmed_abstract":["<h4>Objectives</h4>Acute type A aortic dissection is a life-threatening cardiovascular disease commonly seen in emergency department, resulting in substantial mortality and morbidity. We aimed to investigate the prognostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) among this critically ill population.<h4>Design</h4>The design of this study was a retrospective cohort study.<h4>Setting</h4>The study population was recruited in the Emergency Department of Fuwai hospital in China from 2018 to 2020.<h4>Participants</h4>We consecutively enrolled 829 patients with acute type A aortic dissection and measurable baseline NT-proBNP.<h4>Primary outcome</h4>The primary endpoint was 1-year all-cause death.<h4>Results</h4>Based on tertiles of NT-proBNP (pg/mL), patients were stratified into low (≤150.3, n=276), intermediate (150.3-667.6, n=277) and high (>667.6, n=276) NT-proBNP groups. Compared with patients with low NT-proBNP, the Kaplan-Meier estimates for primary 1-year mortality were higher in intermediate (32.5% vs 18.1%; HR 1.91, 95% CI 1.35 to 2.69) and high (42.0% vs 18.1%; HR 2.56, 95% CI 1.84 to 3.57) NT-proBNP groups, respectively. After multivariable regression adjusted for confounders, NT-proBNP tertiles were independent predictors for 1-year mortality (adjusted HR for intermediate group 1.52, 95% CI 1.02 to 2.27; adjusted HR for high group 2.17, 95% CI 1.41 to 3.32). Notably, the predictive performance of NT-proBNP for 1-year mortality was greater in patients receiving surgery than conservative treatment (between-cohorts difference in area under the curve 0.13, Delong's test p=0.04).<h4>Conclusion</h4>NT-proBNP provides incremental prognostic information for mortality in patients with acute type A aortic dissection who underwent surgical repairment, which could aid in risk stratification as a pragmatic and versatile biomarker in this critically ill population while having limited prognostic value for those receiving conservative treatment."],"journal":["BMJ open"],"pagination":["e093757"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11781122"],"repository":["biostudies-literature"],"pubmed_title":["Clinical implication of NT-proBNP to predict mortality in patients with acute type A aortic dissection: a retrospective cohort study."],"pmcid":["PMC11781122"],"pubmed_authors":["Fu R","Yuan S","Dou K","Liu Q","Song C","Gao J","Cui X","Liu S","Wang H","Zhang R","Liu W","Qin S","Zhu C","Li Y","Bian X"],"additional_accession":[]},"is_claimable":false,"name":"Clinical implication of NT-proBNP to predict mortality in patients with acute type A aortic dissection: a retrospective cohort study.","description":"<h4>Objectives</h4>Acute type A aortic dissection is a life-threatening cardiovascular disease commonly seen in emergency department, resulting in substantial mortality and morbidity. We aimed to investigate the prognostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) among this critically ill population.<h4>Design</h4>The design of this study was a retrospective cohort study.<h4>Setting</h4>The study population was recruited in the Emergency Department of Fuwai hospital in China from 2018 to 2020.<h4>Participants</h4>We consecutively enrolled 829 patients with acute type A aortic dissection and measurable baseline NT-proBNP.<h4>Primary outcome</h4>The primary endpoint was 1-year all-cause death.<h4>Results</h4>Based on tertiles of NT-proBNP (pg/mL), patients were stratified into low (≤150.3, n=276), intermediate (150.3-667.6, n=277) and high (>667.6, n=276) NT-proBNP groups. Compared with patients with low NT-proBNP, the Kaplan-Meier estimates for primary 1-year mortality were higher in intermediate (32.5% vs 18.1%; HR 1.91, 95% CI 1.35 to 2.69) and high (42.0% vs 18.1%; HR 2.56, 95% CI 1.84 to 3.57) NT-proBNP groups, respectively. After multivariable regression adjusted for confounders, NT-proBNP tertiles were independent predictors for 1-year mortality (adjusted HR for intermediate group 1.52, 95% CI 1.02 to 2.27; adjusted HR for high group 2.17, 95% CI 1.41 to 3.32). Notably, the predictive performance of NT-proBNP for 1-year mortality was greater in patients receiving surgery than conservative treatment (between-cohorts difference in area under the curve 0.13, Delong's test p=0.04).<h4>Conclusion</h4>NT-proBNP provides incremental prognostic information for mortality in patients with acute type A aortic dissection who underwent surgical repairment, which could aid in risk stratification as a pragmatic and versatile biomarker in this critically ill population while having limited prognostic value for those receiving conservative treatment.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-04T22:23:59.864Z","creation":"2025-04-04T22:23:59.864Z"},"accession":"S-EPMC11781122","cross_references":{"pubmed":["39880420"],"doi":["10.1136/bmjopen-2024-093757"]}}